Trident Lifeline Limited (TLL) is an India-based medication provider. The Company produces and sells finished doses. Its geographical segment includes India, Ghana, Kenya, Peru, Cameroon, Venezuela, and the Rest of the World. It discovered manufacturing formulations under its own brands alongside a loan license and a contract manufacturing model. It deals in capsules, tablets, liquid ointments, gels, ice gels, mouthwash, paste, solution, suspension, toothpaste, syrup, and cream. The product portfolio of the Company comprises a wide range of drugs like Anti-Bacterial, Anti-Diarrheal, Anti-Fungal, Anti-Malarial, Anti-Diabetic, Dental Cure, Pr, Multivitamin, Multimineral Nyteraceutoton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Anti-Lipidemic Drug, Anti-Parasiticical and Non-steroidal anti-inflammatory drugs (NSAIDS).As of 25 May 2026, Trident Lifeline Limited share price is ₹254.00. The stock opened at ₹250.00, compared to its previous close of ₹248.70. During today's trading session, Trident Lifeline Limited share price moved in the range of ₹249.90 to ₹259.80, with an average price of ₹254.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹249.90 and a high of ₹259.80.
The market capitalization of Trident Lifeline Limited is ₹297 Crs, with a P/E ratio of 15.4 and a dividend yield of 0.00%.